Multimedia About Institute Announcements
- Neurobiobank/Jill Bolte Taylor
Jill Bolte Taylor, Ph.D., a spokesperson for the Harvard Brain Tissue Resource Center, discusses why brain donation truly is the gift of hope.
- Community-based Treatments Offset Depression Disparities
Depression can affect anyone, but it hits ethnic groups more heavily because the poor often have less access to quality health care. To offset this imbalance, researchers from the RAND Corporation and UCLA, and community partners from more than two dozen community agencies, compared whether evidence-based quality improvement programs, which include psychotherapies such as cognitive behavioral therapy and antidepressant medications, are better implemented through involvement of the entire community or through clinic-based programs. The findings, which show the former to be the case, are reported in two papers published online by the Journal of General Internal Medicine. Project officer and Associate Director of Dissemination and Implementation Research at the National Institute of Mental Health David Chambers, Ph.D., discusses the significance of these findings.
- Workings of an Alzheimer’s Gene
NIH-funded scientists have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer’s disease. It’s based on unclogging removal of toxic debris that accumulates in patients’ brains, by blocking activity of a little-known regulator protein called CD33. Too much CD33 activity may promote late-onset Alzheimer’s by preventing support cells from clearing out toxic plaques. Future medications that impede CD33 activity might help prevent or treat the disorder. Dr. Thomas Lehner, director of NIMH’s Office of Genomics Research Coordination, explains the significance of the new findings.
- Project Achieve Weight Loss Trial for People with Serious Mental Illness
NIMH grantee Dr. Gail Daumit talks about the Project Achieve weight loss trial.
- Five Mental Disorders Share Some of the Same Genes
Bruce Cuthbert, Ph.D., director of NIMH’s Division of Adult Translational Research, explains the significance of recent study findings for diagnosis and treatment of mental illnesses.
- NIMH’s Dr. Maura Furey on scopolamine research
Dr. Maura Furey on the search for a fast acting anti-depressant.